| # | Drug | Count |
|---|---|---|
| 0 | DORAVIRINE, LAMIVUDINE, AND TENOFOVIR DISOPROXIL FUMARATE | 5 |
| 1 | LAMIVUDINE | 5 |
| 2 | LAMIVUDINE ORAL | 5 |
| 3 | CISPLATIN | 1 |
| 4 | DOXORUBICIN | 1 |
| 5 | DOXORUBICIN HYDROCHLORIDE | 1 |
| 6 | ETOPOSIDE | 1 |
| 7 | OSILODROSTAT | 1 |
| 8 | SPIRONOLACTONE | 1 |
| 9 | ZINC CHLORIDE | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DORAVIRINE, LAMIVUDINE, AND TENOFOVIR DISOPROXIL FUMARATE | 5 | 0.0160 |
| 1 | OSILODROSTAT | 1 | 0.0005 |
| 2 | LAMIVUDINE | 5 | 0.0002 |
| 3 | ZINC CHLORIDE | 1 | 0.0000 |
| 4 | DOXORUBICIN HYDROCHLORIDE | 1 | 0.0000 |
| 5 | ETOPOSIDE | 1 | 0.0000 |
| 6 | CISPLATIN | 1 | 0.0000 |
| 7 | DOXORUBICIN | 1 | 0.0000 |
| 8 | SPIRONOLACTONE | 1 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 5 | 0.0002 |
| 1 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 5 | 0.0001 |
| 2 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 5 | 0.0000 |
| 3 | Provitamin D2 Compound [EPC] | 1 | 0.0000 |
| 4 | Topoisomerase Inhibitor [EPC] | 1 | 0.0000 |
| 5 | Aldosterone Antagonist [EPC] | 1 | 0.0000 |
| 6 | Platinum-based Drug [EPC] | 1 | 0.0000 |